Ryota Nishimori
President at CAC HOLDINGS CORPORATION
Net worth: 623 212 $ as of 2024-03-30
Ryota Nishimori active positions
| Companies | Position | Start | End |
|---|---|---|---|
| CAC HOLDINGS CORPORATION | Director/Board Member | 2016-03-22 | - |
| President | 2020-12-31 | - | |
| Chief Administrative Officer | 2016-03-31 | 2019-03-26 | |
| Corporate Officer/Principal | 2007-06-30 | 2020-12-31 | |
CAC KK
 CAC KK Information Technology ServicesTechnology Services Part of CAC Holdings Corp., CAC Corp. (TY) is a Japanese company that supports all operations related to donations, significantly reducing time and effort while ensuring high transparency and safety. The private company is based in Tokyo, Japan. With standard functions, it can handle various types of applications, such as scholarships, general donations, academic society donations, research and development expenses, and donation applications from patient groups. Astellas Pharma, Novo Pharma, and several other pharmaceutical and medical device manufacturers have introduced this company. Founded in 2014. | Director/Board Member | 2016-02-29 | - |
| President | 2014-03-31 | - |
Career history of Ryota Nishimori
Former positions of Ryota Nishimori
| Companies | Position | Start | End |
|---|---|---|---|
| CAC America Corp. | Director/Board Member | 2010-12-31 | - |
| President | 2010-12-31 | - |
Statistics
International
| Japan | 3 |
| United States | 2 |
Operational
| Director/Board Member | 3 |
| President | 3 |
| Chief Administrative Officer | 1 |
Sectoral
| Technology Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| CAC HOLDINGS CORPORATION | Technology Services |
| Private companies | 2 |
|---|---|
| CAC America Corp. | |
CAC KK
CAC KK Information Technology ServicesTechnology Services Part of CAC Holdings Corp., CAC Corp. (TY) is a Japanese company that supports all operations related to donations, significantly reducing time and effort while ensuring high transparency and safety. The private company is based in Tokyo, Japan. With standard functions, it can handle various types of applications, such as scholarships, general donations, academic society donations, research and development expenses, and donation applications from patient groups. Astellas Pharma, Novo Pharma, and several other pharmaceutical and medical device manufacturers have introduced this company. Founded in 2014. | Technology Services |
- Stock Market
- Insiders
- Ryota Nishimori
- Experience
